Stada Group
Lawanworn Broese Van Groenou is an experienced regulatory affairs professional currently serving as a Senior Regulatory Affairs Manager and Local Pharmacovigilance Officer at STADA Group since August 2021, leading regulatory teams and managing complex regulatory projects for pharmaceutical products in Thailand. Prior to this role, Lawanworn held several positions at DKSH from November 2014 to August 2021, including Assistant Manager in Regulatory Affairs, where responsibilities encompassed client communications and project management for regulatory approvals and product registrations. Earlier career experiences include roles as a Regulatory Affairs Specialist and Assistant, as well as an internship at Baxter International Inc. Lawanworn holds a Doctor of Pharmacy (Pharm.D.) from Chulalongkorn University and a Master of Management in Healthcare and Wellness Management from Mahidol University.
This person is not in any teams
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.